Download Files:
CB-25
SKU
HY-121541-1 mg
Category Reference compound
Tags Cancer, Cannabinoid Receptor, GPCR/G Protein;Neuronal Signaling
$50 – $1,020
Products Details
Product Description
– CB-25 is a ligand of CB1 cannabinoid receptors, acting as a partial agonist. CB-25 enhances Forskolin (HY-15371)-induced cAMP formation in cancer cells but not hCB1-CHO cells[1].
Web ID
– HY-121541
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture and light)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C25H41NO3
References
– [1]Cascio MG, et al. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Br J Pharmacol. 2006 Oct;149(4):431-40.
CAS Number
– 869376-63-6
Molecular Weight
– 403.60
Compound Purity
– 99.02
SMILES
– O=C(NC1CC1)CCCCCCCCCCOC2=CC(CCCCC)=CC(O)=C2
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : ≥ 100 mg/mL
Target
– Cannabinoid Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.